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ARTICLE
The lexicon of antimicrobial peptides: a complete
set of arginine and tryptophan sequences
Sam Clark 1, Thomas A. Jowitt2, Lynda K. Harris1,3,4, Christopher G. Knight 5 & Curtis B. Dobson 1✉
Our understanding of the activity of cationic antimicrobial peptides (AMPs) has focused on
well-characterized natural sequences, or limited sets of synthetic peptides designed de novo.
We have undertaken a comprehensive investigation of the underlying primary structural
features that give rise to the development of activity in AMPs. We consider a complete set of
all possible peptides, up to 7 residues long, composed of positively charged arginine (R) and /
or hydrophobic tryptophan (W), two features most commonly associated with activity. We
found the shortest active peptides were 4 or 5 residues in length, and the overall landscapes
of activity against gram-positive and gram-negative bacteria and a yeast were positively
correlated. For all three organisms we found a single activity peak corresponding to
sequences with around 40% R; the presence of adjacent W duplets and triplets also con-
ferred greater activity. The mechanistic basis of these activities comprises a combination of
lipid binding, particularly to negatively charged membranes, and additionally peptide aggre-
gation, a mode of action previously uninvestigated for such peptides. The maximum specific
antimicrobial activity appeared to occur in peptides of around 10 residues, suggesting
‘diminishing returns’ for developing larger peptides, when activity is considered per residue of
peptide.
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ntimicrobial peptides (AMPs) are short amino acid
sequences that kill or inhibit the growth of
microorganisms1, and which have diverse and broad
mechanisms of action. They occur naturally as a component of
innate immunity, and are produced widely by many diverse
organisms2,3, although they can also be designed de novo from
natural or non-natural amino acids4–6. The presence of a high
proportion of cationic and hydrophobic residues are two features
commonly associated with AMP activity. Cationic residues (e.g.
Arginine, R, Lysine, K or Histidine, H) are thought to mediate
interactions with negatively charged bacterial lipids, whereas
hydrophobic residues (e.g. Tryptophan, W, Phenylalanine, F or
Leucine, L) mediate membrane association and/or damage.
Naturally occurring AMPs are typically >15 amino acids in
length, although active synthetic peptides <10 residues have been
reported5,7. These have the advantage of low cost if used phar-
maceutically, however shorter peptides typically have reduced
antimicrobial efficacies relative to longer AMPs7–9.
The hydrophobic and cationic residues most characteristic of
shorter AMPs are W and R10,11. The aromatic and hydrophobic
residue W in particular has been associated with antimicrobial
activity12–15. Perturbing the bacterial cytoplasmic membrane is
the most commonly studied mode of action for AMPs, including
short cationic peptides15. This can occur through a number of
proposed mechanisms, including the barrel stave and toroidal
pore models, in which peptide monomers insert into the mem-
brane and form structured pores, resulting in increased lysis, or
the carpet model, in which peptides accumulate on the bacterial
surface, causing stress on the membrane, which tears causing
lipid removal5,16.
Peptide aggregation prior to contact with membrane may also
be required for activity for some AMPs, although this is at present
uncertain17. We have previously reported that the self-aggregating
amyloid β (Aβ) peptide associated with senile plaques in Alzhei-
mer’s disease (AD) is upregulated in response to infection18, and
others report that it may function as a conventional AMP19,20.
More broadly, although some degree of peptide aggregation is
likely to occur for most hydrophobic AMPs in aqueous solution,
surprisingly the role of aggregation in conferring or inhibiting
antimicrobial efficacy remains largely unstudied.
We have previously examined the impact of systematic and
complete substitution of all eight hydrophobic L residues in apoE-
derived cationic AMPs with any other single natural amino acid.
Of these, W substitution clearly yielded the most efficacious and
broadly active peptide12, and reflected increased membrane per-
turbation by the W variant13. In other AMPs, W and R residues
have been reported to associate with each other through deloca-
lised π-electrons, with the side-chains of both residues lining up,
allowing hydrogen bonding between the R residues and the sol-
vent. This allows R (but not the other strongly cationic natural
amino acid K) to insert into a lipid membrane by masking its
charge within the benzene ring of W14.
W and R are the two natural residues most closely associated
with AMP activity perhaps due to their being the most hydro-
phobic or cationic residues, respectively21. Although indirect
evidence supporting the importance of W and R in conferring
antimicrobial activity has emerged, to date their role has not been
addressed directly. More specifically, the antimicrobial activity of
the native W or R amino acids and the development of efficacy as
these residues are systematically combined in peptides of
increasing size and in most or all possible permutations has not
previously been examined. Additionally, it is unclear what mode
of action would predominate in this emerging family of peptides.
Peptide ‘combinatorial space’ is very large (considering only 10-
residue peptides and the 20 natural amino acids there are 2010=
1013 possible sequences; i.e. around hundred times the reported
number of neurons in the brain). No studies have previously
investigated activity within a complete set of peptides, comprising
all possible peptides generated according to a specific formula,
from individual residues upwards. However, a focus on W and R
as key determinants of antimicrobial activity, drastically reduces
the space of possible sequences (for two amino acids there are
only 254 possible peptide sequences across all lengths from
one–seven residues), enabling such a comprehensive approach.
In the present study we have synthesised a peptide library
comprising all possible sequences up to seven residues in length
that can be produced from W and R. We have characterised the
emergence of antimicrobial efficacy against medically relevant
organisms, assessed haemolytic activity (as an indicator of
mammalian cell toxicity) within this peptide space and identified
size and sequence characteristics associated with activity. We
examined the mode of action of these peptides and established
whether this correlates with peptide aggregation and/or affinity
for negatively charged or neutral membranes. These observations
enable us to make several broad conclusions about AMPs con-
structed from hydrophobic and cationic residues alone.
Results
Antimicrobial activity. We considered all possible sequences of
W and R, up to seven residues long. These two amino acids are
closely associated with AMP activity, however, the shortest
‘peptides’ assayed were the individual amino acids, which we
expected to be inactive. In this way we uncovered the develop-
ment of antimicrobial activity in fine detail. We obtained values
for microbial inhibition (half maximal inhibition, IC50; Fig. 1a, b)
and microbicidal activity (minimum biocidal concentration,
MBC; Supplementary Fig. 1a) for 252 of the 254 sequences in this
space (the remaining two sequences were so hydrophobic that
they could not be synthesised—we therefore considered these to
be in effect inactive). Organisms tested were the gram-positive
bacterium Staphylococcus aureus, the gram-negative bacterium
Pseudomonas aeruginosa and the yeast Candida albicans.
Antimicrobial activity increased with peptide length for all
organisms. The minimum length necessary for measurable
inhibitory activity was four residues for S. aureus, or five for
the other two organisms (Fig. 1a). Similarly, MBC values could
only be determined for peptides with a minimum of four (S.
aureus), six (P. aeruginosa) or five (C. albicans) residues
(Supplementary Fig. 1b). Not only was antimicrobial activity
only seen in longer peptides, the extent of activity was positively
correlated with length (Fig. 1b and Supplementary Fig. 1d).
Overall, antimicrobial activity was highest for S. aureus > C.
albicans > P. aeruginosa, with most peptides in the heptamer
group (which comprised approximately half the library) showing
activity. Minimum heptamer IC50 concentrations were 1.9, 10.3
and 15 µM for S. aureus, C. albicans and P. aeruginosa, with 92.2,
81.3 and 60.2% of heptamers showing measurable IC50
concentrations against these three organisms (Fig. 1a). MBC
values followed a similar pattern with the minimum MBC values
for heptamers being 9.6, 18.7 and 42 µM for S. aureus, C. albicans
and P. aeruginosa, respectively, with 60.2, 60.2 and 10.2% of
heptamers showing measurable MBCs against these three
organisms (Supplementary Fig. 1a). We found a strong correla-
tion between IC50 and MBC for each of the three organisms for
the entire peptide set (S. aureus: ρ= 0.73, P < 2.2 × 10−16, S129=
101042; C. albicans: ρ= 0.93, P < 2.2 × 10−16, S114= 17027; P.
aeruginosa: ρ= 0.78, P= 2.375 × 10−5, S19= 384.42).
The absolute activities of each peptide molecule expressed by
plotting the inhibitory concentration in µM presented in Fig. 1a, b
is helpful in understanding how activity increases with peptide
length. A further insight is provided by considering ‘specific
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Fig. 1 Antimicrobial activity for the complete set of peptides comprised of W and R up to 7 residues long. a Activities are represented for peptide
sequences arranged using a concentric ring chart system (referred to as ‘Harris-Clark diagrams’). Each peptide can be identified by reading the sequence
from the N-terminal residue in each ring towards the C-terminal residue at the centre of the chart; inhibitory activity (IC50) is indicated for that peptide by
the colour of shading in the outermost compartment (i.e. the compartment identifying the N-terminal of each peptide). The three separate Harris-Clark
diagrams show the inhibitory activities against S. aureus, P. aeruginosa and C. albicans. Grey sections represent peptides which did not exhibit an IC50 within
the range of concentrations assayed (0.8–400 µM). The two peptides which could not be synthesised are indicated by black sections with white lettering.
Similar plots for MBC are shown in Supplementary Fig. 1. b Effect of peptide length on harmonic means and standard deviations for IC50 and EC50. Similar
plots for MBC are shown in Supplementary Fig. 1. All error bars shown are ±s.d. (n= 2, 4, 8, 16, 32, 64 and 126 peptides for lengths 1–7, respectively) c
Specific activities of each peptide plotted against length. Quantile regressions (90% quantile), represented by coloured lines, show the trend of specific
activity with length. The solid vertical lines indicate the predicted peptide length with the greatest specific activity, and the dotted lines indicate the 95%
credibility interval for this prediction generated by sampling from the posterior distribution of a Bayesian model (see Methods). The distribution of
haemolytic activity for individual peptides is shown in (d) and of turbidity of 800 µM stock solutions (ODvis) in (e), whereas (f) shows ODvis of the same
stock solutions plotted against peptide length.
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activity’, i.e. how the peptide size influences the increase in
activity from adding on further residues. In this way we could
determine whether this assessment of specific activity (activity per
residue) has a peak, if so suggesting that then adding further
residues will lead to lower overall activity per unit mass of
peptide. We estimated this length using data for the complete
peptide library as shown in Fig. 1c. The peptide lengths with
maximal specific activity were estimated at 8 (7.08–8.75, 95% CI)
residues for S. aureus, and 11 residues for P. aeruginosa
(8.77–15.2) and C. albicans (8.63–15.2).
Haemolytic activity. Haemolytic activity was detectable for fewer
peptides than antimicrobial activity; only 40 peptides had an EC50
within the concentration range assayed. Only peptides longer
than four residues in length displayed measurable haemolytic
activity and, as observed for antimicrobial activity, there was a
positive association between haemolytic activity and peptide
length (Fig. 1b, d and Supplementary Fig. 1c). These values can be
used to normalise the antimicrobial activity (IC50) to give a
‘therapeutic index’ indicating the increase in efficacy of the
peptides against a particular microbe relative to mammalian cells
(Supplementary Fig. 1e).
Solution turbidity. Measurement of the turbidity (ODvis) of each
peptide solution, which was used as a means of broadly assessing
the extent of peptide aggregation, revealed that some peptides with
five or more residues, and in particular those containing higher
numbers of W residues, exhibited increased turbidity (Fig. 1e, f).
This may reflect reduced solubility or an increased propensity to
aggregate, thereby producing large visible structures. These pep-
tides typically showed low activity, with the exception of the
cluster of peptides ending with ‘WWRWW’(in the upper left of
Fig. 1e). These sequences exhibited potent activity, particularly
against S. aureus, despite producing turbid solutions.
Sequence-activity relationships. The landscapes of sequence-
activity relationships (Fig. 1a and Supplementary Movie 1) con-
tain a ‘corridor’ of inactivity (from the centre to the uppermost
region of the circles in Fig. 1a) corresponding to peptides com-
prising only W or only R. This illustrates the importance of a
mixture of the two residues underpinning activity. Efficacy was
typically highest against all organisms for heptamer peptides
containing 3R and 4W residues, although this ratio may be less
critical for S. aureus, as the peak was broader (Fig. 2a and Sup-
plementary Movie 1). Nonetheless, small differences in sequence
could be associated with large differences in activity, for instance,
the heptapeptide WWWRRRW is highly active (IC50= 2.9 ± 0.3
µM) but changing one residue, to WWWRRRR increases the IC50
65-fold (Fig. 1a and Supplementary Movie 1). Such variability in
antimicrobial activity with sequence can be characterised by
calculating the roughness to slope (r/s) ratio of the peptide
landscape at each length (Fig. 2f). This value increased with
length, indicating that the spread of possible activities becomes
greater with increased peptide length and complexity.
Because of this landscape complexity, we applied a machine
learning feature selection algorithm to identify sequence features
associated with antimicrobial activity in the complete peptide
library (Supplementary Table 1). As expected from Fig. 2a, a key
feature important for activity against all of the organisms studied
was W content. Typically, for penta-, hexa- and heptapeptides,
those with ~60% W content exhibited the lowest IC50 concentra-
tion against all organisms (Fig. 2b), with a similar trend apparent
for the MBC (Supplementary Fig. 2a). Heptapeptides containing
70–80% W had the most potent haemolytic activity (lowest EC50
values) (Fig. 2e). The ODvis typically increased with W content,
suggesting increasing hydrophobicity was associated with either
insolubility or propensity to aggregate (Fig. 2d).
Another key feature associated with antimicrobial activity was
presence of multiple adjacent W residues (Supplementary
Table 1). While W singleton (isolated W residues in the
sequences) showed no correlation with antimicrobial activity,
there were positive correlations of antimicrobial activity with both
duplet (WW) and triplet (WWW) content (Fig. 2c). These
findings suggest clustering of W residues as doublets or triplets is
important for antimicrobial activity. No similar relationships
were observed for R residues (Supplementary Fig. 2b).
We considered the possibility that endogenous cleavage of the
peptides by proteases might affect activity. As almost all naturally
occurring proteases would cleave our peptides either just after W or
R, indicating extent of cleavage by different proteases would simply
depend on the amount of R and W in each sequence. One
exception was pepsin, which cleaves after W depending on the
position of R within the sequence. This was therefore examined
using in silico analysis, in which the number of pepsin fragments
likely from each of our peptides was plotted against antimicrobial
activity (Supplementary Fig. 3a). We identified correlations between
likely number of pepsin fragments and activity, which varied among
organisms and peptide lengths. We also considered whether
hydrophobic moment might be associated with activity, and found
evidence for weak positive correlations (Supplementary Fig. 3b).
Heptapeptide aggregation. ODvis measurements (Fig. 1f) suggest
that more aggregation occurs in some longer peptides. A model of
these indicates that, having accounted for the effect of length, the
residual correlation between peptide ODvis and IC50 against all
organisms, is weakly negative (−0.09 [−0.17 to −0.01 95% CI]).
In other words, this aggregation is, if anything, beneficial to
peptide activity. We therefore used dynamic light scattering
(DLS) to measure the typical size of aggregates among the longest
(7-residue) peptides. Heptapeptides fell into three classes: those
producing small aggregates (diameter < 10 nm), moderate
aggregates (10 nm < diameter < 104 nm) or large aggregates
(diameter > 104 nm) (Fig. 3a). The ODvis distributions for hep-
tapeptides differed noticeably among aggregate classes, with those
forming large aggregates having significantly higher ODvis values
than heptapeptides producing small aggregates (Fig. 3b). This is
likely to be due to larger aggregates scattering more light,
resulting in higher measured turbidity. Percentage W content was
also positively associated with aggregate size (Fig. 3c). Tendency
to produce large aggregates was negatively associated with anti-
microbial activity, compared to peptides in the other two aggre-
gation states, irrespective of microbial species (Fig. 3d). A similar
association was found with MBC (Supplementary Fig. 4). Hae-
molytic activity showed no significant relationship with aggre-
gation state (Fig. 3e).
To test whether heptapeptide aggregation was concentration-
dependent and reversible, aggregation was re-examined by
analytical ultracentrifugation (AUC), using 80 µM dilutions of
the three heptapeptides that exhibited substantial aggregation at
800 µM (as measured using DLS). Each peptide formed aggregate
structures <5 kDa, suggesting that, at most, tetrameric aggregates
(~4.8 kDa) are present (Fig. 3f). This concentration-dependent
effect on aggregate size was corroborated by transmission electron
microscopy of WRWWWWW. Substantial visible aggregates
were present at 800 µM but not at 80 µM (Fig. 3g). Together these
findings suggest that heptapeptide aggregates disperse at lower
concentrations.
Membrane binding of heptapeptides. Negatively charged bac-
terial membranes are frequently considered to be a specific
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02137-7
4 COMMUNICATIONS BIOLOGY |           (2021) 4:605 | https://doi.org/10.1038/s42003-021-02137-7 | www.nature.com/commsbio
molecular target for positively charged AMPs. We therefore used
a quartz crystal microbalance with energy dissipation (QCMD) to
test the membrane association of 29 heptapeptides (comprising
20 pairs of heptapeptides possessing the largest differences in
activity whilst differing by only a single substitution in the
sequence, Supplementary Fig. 5) with model negatively
charged (anionic) or neutral lipid membranes. These composi-
tions represent typical bacterial or mammalian cell membranes,
respectively22 The mass of bound heptapeptide was highest for
neutral membranes for those heptapeptides with either four or
five W residues, and for the anionic model membranes for hep-
tapeptides with 4 W residues (Fig. 4a). A significant positive
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correlation was observed between the distribution of R through
the sequence (positional standard deviation) and heptapeptide
mass bound to anionic model membranes (ρ= 0.49, P= 0.004,
S27= 3040.6) (Fig. 4b). Interestingly, the same correlation was not
seen between the distribution of R and the mass bound to neutral
membrane (ρ= 0.04, P= 0.83, S27= 5241.7).
A positive relationship between activity and binding to both
neutral and anionic model membranes was also identified
(Fig. 4c–e), although the correlation was stronger for anionic
membrane binding (S. aureus: ρ= 0.61, P= 2.5 × 10−4, S27=
9609.9; P. aeruginosa: ρ= 0.74, P= 2.1 × 10−4, S27= 10437; C.
albicans: ρ= 0.59, P= 4.4 × 10−4, S27= 9488.6) than neutral
membrane binding (S. aureus: ρ= 0.39, P= 0.26, S27= 7608.2; P.
aeruginosa: ρ= 0.26, P= 0.14, S27= 6897.5; C. albicans: ρ= 0.50,
P= 3.6 × 10−3, S27= 8207.6). In contrast, the correlation of
haemolytic activity with neutral membrane binding (ρ= 0.76, P
= 1.45 × 10−6, S27= 9636.7) was stronger than that with anionic
membranes (ρ= 0.32; P= 0.06, S27= 7952.4) (Fig. 4f). Bacterial
membranes are more negatively charged than mammalian
membranes, and thus our data are consistent with antimicrobial
activity for these peptides relating to their binding negatively
charged membranes and their mammalian cell cytotoxicity
originating in their neutral membrane binding.
Morphological changes induced by heptapeptides. Finally, we
compared the effect of an inactive heptapeptide (RRRRRRR) and
one of the most active heptapeptides (RWWRWWR) on bacterial
morphology after a short exposure. Scanning electron microscopy
of P. aeruginosa revealed no discernible change in morphology
between the control bacteria and those treated with the inactive
RRRRRRR, at 80 or 400 µM for 1 h (Fig. 5a). However, exposure
to the highly active heptapeptide RWWRWWR (80 µM; 1 h)
resulted in the formation of spheroid objects on the surface of the
bacteria, indicative of membrane blebbing (indicated by the black
arrows in Fig. 5a. Furthermore, treatment of bacteria with a 400
µM solution of RWWRWWR for 1 h resulted in a dramatic
reduction in the number of intact bacteria visible in the sample,
and the presence of large amounts of smaller irregular material
(indicated by the white arrows in Fig. 5a).
Atomic force microscopy of P. aeruginosa treated with 100 µM
RWWRWWR (for 2–45 min) highlighted significant morpholo-
gical differences through treatment. Mean bacterial width
decreased by a third and height doubled after only a 2 min
exposure (Fig. 5b, c). These SEM and AFM findings together
suggest that peptide activity involves rapid perturbation of
bacterial membranes, firstly changing cell shape, then later
inducing observable morphological irregularities, which, at higher
concentrations, results in bacterial cell lysis.
Discussion
Our approach of characterising the biological activity of all pos-
sible peptides up to seven residues comprising R and W, enables
us to make some general conclusions about the rules governing
the activity of synthetic AMPs comprising cationic and hydro-
phobic residues. Although previous studies have provided anec-
dotal examples of the impact of sequence changes on the activity
of several such peptides23, we examine these effects using a
complete set of all peptides possible within a theoretical universe,
and therefore we can more reliably make broad conclusions at
least for the peptide class studied. It should be noted that our aim
was to provide fundamental insights into the rules governing the
development of activity in this class of peptides, and we did not
expect to identify highly potent sequences suitable as potential
clinical lead compounds24.
We established the minimal length of peptide required for
activity to be 4–5 residues (to obtain a measurable IC50 value) and
4–6 residues (to obtain an MBC) for the three organisms tested.
Although a measurable MBC is a key attribute of an AMP, as we
focused on investigating the development of antimicrobial activity
in this peptide set, we also considered IC50 values to be important
as an indicator. Indeed we found that IC50 concentrations were
likely to be a good indicator of activity overall, since the IC50 and
MBC against each organism was highly correlated for peptides in
the set which exhibited activity in both metrics.
In general, activities were broadly similar for all three organ-
isms, although more peptides showed activity against S. aureus
and C. albicans than against P. aeruginosa (in particular when
assessed by measuring MBC), perhaps reflecting greater resistance
of the gram-negative organism conferred by its outer membrane.
These findings might be confirmed by extending testing to a
broader range of organisms. The minimal peptide length we
uncovered is consistent with other reports in the literature for
isolated examples of peptides, where activity typically only
occurred for sequences of naturally occurring amino acids >4–5
residues in length2. One previous study has reported detectable
activity for dimer peptides25; however such activities would not of
been measurable in our study due to the extremely high con-
centration of peptide required (in the mM range, where we tested
up to 400 µM). A minimum length of two residues has been
reported to be necessary to form a β-sheet structure, while a
minimum length of four residues is needed for α-helical
structure26, with the latter structure in particular considered
important for activity of some AMPs26. It would have been
interesting to confirm this by characterising the structure of our
peptides using circular dichroism, however this was not possible
in practise due to the high levels of W, and propensity of the
peptides to aggregate. As W and R are, respectively, the most
hydrophobic and cationic naturally occurring residues, it seems
reasonable to conclude this represents the lower size limit for the
activity for all peptides composed of naturally occurring amino
acids. Some studies have reported activity in shorter peptides
composed of non-natural amino acids27. Whether this is due to
more potent mechanisms of action available via non-natural
amino acids, or simply more rapid catabolism of natural amino
acids is unclear. However, it suggests that the conclusions of our
Fig. 2 Effect of various peptide primary structural features on activity. a Activity (IC50) presented as a three-dimensional representation illustrating (as a
landscape) the influence of the number of W and R residues on activity against the three different organisms. b Inhibitory activity plotted against
percentage W residues within the sequence, faceted by peptide length (indicated at the top of each sub panel). The black spline through the data indicates
the average activity for each peptide length. Error bars are within the markers and are ±s.e.m. (n= 4). Similar plots for MBC are shown in Supplementary
Fig. 2a. c Analysis of average inhibitory and haemolytic activities for peptides with different numbers of isolated W singlets (W), duplets (WW) and triplets
(WWW), faceted by peptide length (indicated at the top of each sub panel). Error bars shown are ±s.e.m. Similar plots for R, RR and RRR are shown in
Supplementary Fig. 2b d Effect of percentage W content on average ODvis, faceted by peptide length (indicated at the top of each sub panel). Error bars
shown are ±s.e.m. (n= 4). e Haemolytic activity plotted against percentage W residues within the sequence, faceted by peptide length (indicated at the
top of each sub panel). The black spline through the data indicates the average activity for each peptide length. Error bars are within the markers and are
±s.e.m (n= 4). f Roughness analysis, indicating the extent of variability of activity across the three different antimicrobial activity landscapes. Error bars
shown are ±s.e.m. (n= 100 in all cases).
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study may not extend to non-natural sequences (which are often
used to stabilise clinical lead AMPs).
Our preliminary in silico analyses of our primary sequences
uncovered only one protease (pepsin) which might cleave in a
sequence specific manner. We found that the likely theoretical
extent of pepsin digestion did correlate with activity. However,
as pepsin is a gastric protease and is most active at low pH, it is
unlikely to be present or active during our MIC testing.
Nonetheless, more widely, propensity to aggregate might
indirectly affect the accessibility of cleavage sites. In further
studies it would therefore be important to confirm whether
peptides within our library, in aggregation states typical at
active concentrations, are differentially digested by common
endogenous proteases.
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A second general conclusion is that overall activity increases
consistently with length. However, extrapolations of the rela-
tionship between activity and peptide length suggest that the
specific activity peak (i.e. the length of peptide above which
further additions decreases activity per residue) occurs below 20
residues, with the best estimate being at around ten residues. We
previously reported variable activity in a group of cationic and
hydrophobic AMPs based on apoE-derived AMPs, and a range of
similar peptides we tested. Notably apoE-derived peptides
(composed of the hydrophobic residues W, and the cationic
residues R and K) showed reduced antibacterial activity as they
were shortened from the 18mer ApoEdpL-W
(WRKWRKRWWWRKWRKRWW, minimum IC50 7 µM in P.
aeruginosa) to 15mers or shorter. Conversely, the heptamer
peptide RWWRWWR had relatively high activity (minimum IC50
14 µM in S. aureus), despite being much shorter than inactive
9mer or 12mer truncations of ApoEdpL-W, as did the similar Y-
containing octapeptide RRWYRWWR (minimum IC50 of 21 µM
in both S. aureus and P. aeruginosa)28. It is possible that the
introduction of K residues in ApoEdpL-W may have imparted
behaviour beyond that observed in peptides composed of W and
R alone. However, in our current work, such disparate patterns
are also present, with short active peptides and longer, less active
peptides, within a wider pattern of increasing activity with length
(Fig. 1a and Supplementary Movie 1). Thus our general obser-
vation that the activity increases with length does not mean that
truncating a particular 18mer will not strongly impact activity for
that single peptide. Calculating specific activity (i.e. activity per
residue) helps us make such comparisons; while they are longer,
both the octapeptide described above and ApoEdpL-W have
specific activities well within the ranges explored here (126 and
168 µM, respectively, cf. Fig. 1c).
Longer peptides were associated with increases in average and
maximum activity, and also in the variability of activity for a
peptide of the same length. This is observed both in the increasing
spread of activities in Figs. 2b and 1c, and in the increase in the
roughness of the sequence-activity landscape with peptide length
(Fig. 2f). This observation partly reflects an increasing maximum
activity with length, while keeping the same minimum of inac-
tivity, but also reflects the occurrence of some exceptional longer
peptides with relatively high activity. However, to identify more
of such peptides would require searching ever-larger sequence
spaces. In this study we start to define design rules, such as the
role of W clusters (Fig. 2c), on which rational design within such
vast spaces may be possible. However, these rules appear
incomplete as, for example, they do not explain the highlighted
65-fold difference in activity between WWWRRRR and
WWWRRRW.
Alternatively, without relying on design rules, searching such
spaces using iterative evolutionary approaches may be effective29,
as it is for aptamer identification, either in vitro (e.g. via the
SELEX process30) or in silico29. Appropriate algorithm selection
is critical to exploring such large landscapes effectively and effi-
ciently. For example, an algorithm starting with the best available
peptide, considering variations upon it, taking the best of those
and then iterating would be effective if there were a single optimal
peptide and single steps away from it were progressively worse.
However, this is far from the case in practice (Fig. 1a and Sup-
plementary Movie 1), meaning that more complex algorithms
would be required. Complete peptide landscapes, such as those
presented here, may therefore provide a means to test and
develop algorithms tailored to deal with the nuances of AMP
sequence-activity relationships.
Activity was higher in peptides containing slightly more W
than R, with this being the case for peptides of different length
and for different microorganisms (Fig. 2b). W is the most
hydrophobic naturally-occurring amino acid31–33, due to its
indole ring, a bicyclic structure comprising conjoined benzene
and pyrrole rings13. The indole ring may enable the stable
insertion of the peptide into the cellular membranes of micro-
organisms, as it is most stable at the interface of the hydrophilic
extracellular environment and the hydrophobic interior of the
cellular membrane13. Increasing W residues in the peptide
increase membrane insertion, and also perturbation (we pre-
viously reported that W increases membrane perturbation, in
apoE-derived AMPs28), thereby increasing efficacy. In the present
study we found that heptapeptides containing four W showed the
most extensive binding to anionic membranes (Fig. 4a, which are
chemically more representative of bacterial membranes), with this
correlating with the proportion of W found to be most efficacious
(Fig. 2b), suggesting a close relationship between membrane
binding and activity across these peptides consistent with pre-
vious findings for similar peptides21,34.
Increasing peptide hydrophobicity seemed likely to be a factor
causing aggregation and indeed we found that peptide aggrega-
tion increased with increasing W (Fig. 3c). We also found that
peptides containing very high proportions of W showed reduced
activity (Fig. 2b) as did those peptides capable of forming very
large aggregates (>104 nm, Fig. 3d), with the latter being larger
than the typical size of a bacterial or yeast cell. Nonetheless
overall aggregation—measured by ODvis was slightly beneficial to
antimicrobial activity, and notably our feature selection analysis
(Supplementary Data Table 1) showed that the six primary
structural features associated with aggregation were also found to
associate with haemolytic activity (EC50). Peptide aggregation was
concentration dependent, with aggregation measured at high
concentrations, so such aggregates may have partly dispersed
when peptides were diluted down to the concentrations tested in
the MIC experiments, although our TEM and AUC findings both
confirm small aggregates are present at 80 μM, within the range of
MIC experiments. Together these relationships suggest that
aggregation is integral to activity until aggregate size becomes
large, at which point activity diminishes due to reduced bioa-
vailability of the active form of the molecule35–37.
Fig. 3 Analysis of heptapeptide aggregation. a Analysis of the size of aggregates for peptides in stock solutions (800 µM) using DLS, indicating the three
size categories identified (featuring small, moderate or large aggregates; n = 47, 72 and 10, respectively). b Box plots indicating ODvis distributions (i.e.
likely overall extent of aggregation) for peptides in each aggregation state. Error bars shown are ±s.e.m. (n= 4). Numbers on brackets indicate the P value
from a post hoc Tukey test of the aggregate states having the same distribution. c Box plots showing percentage W (by number of W residues in
sequence) content distributions for peptides in each aggregation state. Numbers on brackets indicate the P value from a post hoc Tukey test of the
aggregate states having the same distribution. d Antimicrobial activity (IC50) of peptides in each aggregation state for three test organisms. Numbers on
brackets indicate the P value from a post hoc Tukey test of the aggregate states having the same distribution. e Haemolytic activity (EC50) for peptides in
each aggregation state. Numbers on brackets indicate the P value from a post hoc Tukey test of the aggregate states having the same distribution. (n= 254
peptides in a–e). f Analysis of the size of aggregates present for three different peptides found to produce substantial aggregates at 800 µM after a tenfold
dilution (i.e. to 80 µM) and using AUC. g TEM imaging of the peptide WRWWWWW at concentrations of 80 and 800 µM. Scale bars shown are 100 nm
in length.
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An interesting parallel has recently been reported in the AD
field, where the Aβ peptide, whose misfolding and aggregation is
associated with AD, has been shown to function as an AMP20,
potentially ensnaring bacteria in a ‘cage-like’ structure, a process
dubbed bioflocculation19,38. In a further parallel, Aβ is thought to
be most biologically active when it forms smaller aggregates
(oligomers or protofibrils) with larger fibrils being relatively
inert39. Our results suggest that AMPs, at least simple ones of the
type in our complete set, also operate as small aggregates rather
than individually. This may provide an additional explanation
why maximal specific activity is reached for sequence of only
around ten residues (individually too short to span a biological
membrane), as activity is a consequence of clusters of peptides
rather than peptides in monomeric form.
Fig. 4 Membrane binding capacity of heptapeptides. a Comparisons of bound mass of selected heptapeptides to anionic and neutral membranes against
their W content. b Comparison of bound peptide mass to anionic and neutral membranes with distribution of R residues in the peptides (in the form of the
positional standard deviation of R). The solid and dashed lines indicate the linear regression between bound mass and positional standard deviation of R for
anionic and neutral membranes, respectively with the solid and outlined ribbons indicating the 95% confidence interval on the regression lines for the
respective membranes. Analysis of the relationships between bound peptide mass to anionic and neutral membranes and antimicrobial activity against c S.
aureus, d P. aeruginosa and e C. albicans. The solid and dashed lines indicate the LOESS regression between bound mass and log2(IC50) deviation of R for
anionic and neutral membranes, respectively with the solid and outlined ribbons indicating the 95% confidence interval on the regression lines for the
respective membranes. f Analysis of the relationship between bound peptide mass to anionic or neutral membranes and haemolytic activity. The solid and
dashed lines indicate the linear regression between bound mass and log2(EC50) for anionic and neutral membranes, respectively with the solid and outlined
ribbons indicating the 95% confidence interval on the regression lines for the respective membranes. All error bars shown are ±s.e.m. (n= 4) peptides
were used throughout.
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In addition to the proportion of W, the relative positioning of
R and W residues also influenced the extent of antimicrobial
activity (Fig. 2c); clustering of W either as doublets or as a
single triplet increased activity. One explanation may be that
membrane perturbation was increased locally by the presence
of two or three adjacent W residues inserting at adjacent points.
The increase in activity associated with W was not found for
peptides containing only isolated W residues, suggesting adja-
cent hydrophobic residues may be necessary to deliver more
substantial membrane perturbation. Our study also suggested
that an even spread of R residues was important for peptide
binding, though not overall activity. Even distribution of charge
along the length of the peptide has previously been proposed to
improve electrostatic association of AMPs with the microbial
membrane attachment34. This is supported in our study, which
revealed a significant positive association between the posi-
tional standard deviation of R (i.e. the extent to which R is
distributed along the sequence) and the mass of peptide bound
to the membranes observed (Fig. 4b). Notably we did not find
an association between the clustering of R as doublets or tri-
plets, and antimicrobial activity, strongly suggesting R residues
contribute through their distributed effect on membrane
binding, rather than together with other adjacent R residues. R
may function to promote the initial association of the peptide
with the membrane, and so an even spread of R would decrease
competition for binding sites between R residues, and also
ensure that the full length of the peptide is held in proximity to
the surface of the membrane34. This would thereby facilitate
disruptive membrane interactions of W residues, a process
which may take place after initial electrostatic association of the
peptide with the membrane.
Haemolytic activity reflects the potential for an antimicrobial
to have adverse activity against mammalian cells. This shows a
similar relationship with tryptophan content to antimicrobial
activity, though with a higher optimal content W content, close to
80% (Fig. 2e cf. Fig. 2b). This perhaps reflects the diminished
role for R in mediating attraction, given the slightly positive
charge reported for red blood cell membrane, which is typically
+10 to 20 mV22, compared with −20 to −50 mV found for
microorganisms40. Consistent with this, we found that binding of
heptapeptides to neutral membranes was not influenced by even
distribution of R around the peptide, as had been the case for
Fig. 5 Effects of antimicrobial peptides on bacterial ultrastucture. a Appearance of P. aeruginosa bacteria treated with the peptides RWWRWWR and
RRRRRRR at concentrations of 80 and 400 µM, visualised by SEM. A control image of bacteria not treated with peptide is also shown. Black arrow indicates
a localised protrusion (bleb) on the surface of the bacteria. White arrows indicate debris, presumably from lysed bacteria. White scalebars shown are 1 µm
in length. b Appearance of P. aeruginosa bacteria treated with the peptides 80 µM RWWRWWR for various time periods, visualised by AFM. A control
image of bacteria that were not treated with peptide is also shown. White scalebars shown are 2 µM in length. c Quantification of the average change in
size of bacteria after peptide treatment for various times. Boxplots show the long axis, short axis and maximal heights of bacteria in typical AFM images
from (b). Numbers on brackets indicate the P value from a post hoc Tukey test for time points where distributions either end of the bracket are significantly
different. n= 6 cells used for analysis at each time point.
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anionic membranes (Fig. 4b), suggesting that R was less involved
in mediating interactions with non-anionic membranes.
The potential importance of the bacterial cell membrane as the
primary mechanism of action of these peptides was further
supported by the appearance of surface changes including
depressions or external protrusions after a short exposure to the
peptide (Fig. 5a). As the timescales of experiments were neces-
sarily short to test for immediate direct effects, the concentrations
of peptides used were higher than those used in the MIC
experiments, which had involved much longer exposure times.
We therefore cannot exclude that the mode of action taking
precedence after short term exposure to high concentrations is
different from that after overnight incubation and antimicrobial
assays. However the simplest explanation is that in both cases the
changes are mediated by membrane perturbation. Protrusions
have been reported previously following AMP-treatment, and
were associated with loss of cytoplasmic material from the bac-
teria after membrane perturbation41. After exposure to a 400 µM
concentration of active peptide, the bacteria disintegrated, per-
haps due to loss of membrane integrity. Additionally, changes in
both the width and height of the P. aeruginosa rod were observed
using AFM after a very brief (2 min) peptide treatment (Fig. 5b,
c). This suggests a direct effect on membrane fluidity, as treated
bacteria appeared to increase in height, suggesting their mem-
branes may be under greater pressure. This is consistent with
deposition and insertion of AMPs into the membrane, potentially
resulting in greater membrane ‘stiffness’. This is consistent with
previous studies, which have reported that other AMPs induce
loss of membrane fluidity in bacteria42.
In conclusion, we have taken an unprecedentedly compre-
hensive approach to explore the antimicrobial activity of short
peptides, composed exclusively of arginine and tryptophan. We
have determined both the presence and the limits of simple rules
for defining activity across this complete sequence landscape.
This involved characterising simple relationships involving length
and number of hydrophobic residues and confirming how those
differ for antimicrobial and haemolytic activity. Moreover, we
have uncovered striking complexity even within this relatively
‘simple’ system, identifying large variation in activity among very
closely related peptides. Some of this complexity may be caused
by the two main mechanisms of activity we identified as impor-
tant here: aggregation and membrane binding, which are asso-
ciated with changes in cell morphology and death. Further
analysis of complete sequence-activity landscapes for other amino
acids opens the way for studies focused on developing novel
antimicrobials fully synthetically, based on rational design. The
outputs of our study (and further similar ones) may be used as a
compendium of activity associated with specific shorter peptide
motifs, enabling larger peptides with clinical utility to be
assembled.
Methods
Chemicals and media. Dimethyl sulfoxide (DMSO) was obtained from Sigma
Aldrich (Poole, UK). Bacteriological growth media and phosphate buffered saline
(PBS) were obtained from Oxoid (Basingstoke, UK). Defibrinated horse blood was
purchased from EO Labs (Bonnybridge, UK). HEPES was obtained from MP
Biomedicals (Santa Ana,USA) and NaCl was obtained from Fischer Scientific UK
(Loughborough, UK).
Peptide library synthesis. A complete library of peptides comprising all combi-
nations of tryptophan (W) and arginine (R) up to seven residues long was syn-
thesised by Covalabs UK (Cambridge, UK) using 9-fluorenylmethyl-carbamate
chemistry and purified using ultra performance liquid chromatography. Synthesis
of two of the most hydrophobic peptides (WWWWWWR and WWWWWWW)
was unsuccessful. The test library therefore comprised the amino acids R and W, 4
dipeptides, 8 tripeptides, 16 tetrapeptides, 32 pentapeptides, 64 hexapeptides and
126 heptapeptides (252 peptides in all). Peptides were manually synthesised with
trifluoroacetic acid (TFA) counterions and cleavage was performed with TFA, and
C-terminal amidation and N-terminal acetylation carried out for all peptides.
Wang resin was used as the synthesis substrate and peptides were purified on a C18
column. Ninhydrin was used to verify correct coupling of amino acids. Purity was
verified at >80% using matrix assisted laser desorption/ionisation time-of-flight
(MALDI – TOF) mass spectrometry.
Peptide sequence analysis. We identified a set of features to examine for each
peptide sequence (referred to as the ‘feature space’). Components (and the symbols
used to refer to these) included the abundance of each of the amino acids (A%), the
occurrence of amino acid duplets (AA) and triplets (AAA), the mean position of
each amino acid (XA and the positional standard deviation of each amino acid (σA)
(see Supplementary Table 2 for full list). Feature selection was carried out using the
Boruta wrapper algorithm (version 6.0.043) in R. For all Boruta analyses, the entire
feature space available was utilised. The maximum number of iterations performed
by the algorithm (maxRuns) was set at 100,000 for all analysis; this value was
sufficient for the algorithm to reach a decision on all features in all analyses
performed. Hydrophobic moments were calculated based on the methodology
outlined in Eisenberg et al. 198444, taken over windows of four residues, with the
maximal value taken. Pepsin cleavage sites criteria were based on Keil 199245, with
permissible cleavage sites having a W residue in the residue site before the cleavage
site, so long as an R residue is not located three residue positions before the site (i.e.
the motif RxW is not allowed before the cleavage site).
Microorganism culture. S. aureus ATCC 6538 and C. albicans ATCC 10231 were
obtained from Oxoid (Basingstoke, UK), and P. aeruginosa PAO1 donated by the
University of Nottingham. Bacteria were routinely grown using Mueller–Hinton
broth or agar and yeast was grown using Sabaraud Dextrose broth or agar. Cultures
were incubated aerobically on agar at 37 °C for 20 h or under the same conditions
in broth with shaking at 200 rpm.
Antimicrobial assays (IC50 and MBC). Planktonic cultures were obtained by
inoculating single colonies from 18–20 h old agar cultures into 10 ml of sterile
broth, followed by 20-h incubation. S. aureus and P. aeruginosa assays were per-
formed using Mueller–Hinton broth and agar and C. albicans assays were per-
formed using Sabaraud Dextrose broth and agar. Test organisms were isolated by
centrifugation of 1 ml of the culture at 2000 × g for 3 min (MiniSpin®; Eppendorf,
Germany), and resuspending the pellet in 1 ml of fresh sterile broth, before further
dilution in sterile broth, until an optical density at 600 nm (OD600) of 0.8 was
obtained. This was diluted 1:50 in sterile broth, resulting in an inoculum of ~106
colony-forming units per ml (CFU/ml).
Peptide stock solutions of 800 µM were prepared by dissolving solid peptides
(provided in pre-weighed aliquots by the supplier) in phosphate buffer solution
(PBS) containing 5% (v/v) DMSO. Further dilutions of the stock peptides were
prepared (at double the final test concentrations of 0.6–400 µM) in PBS in 5% (v/v)
DMSO. All peptide stocks and dilutions were prepared in polypropylene centrifuge
tubes. About 100 µl of the test inoculum was transferred into the wells of a
polystyrene 96-well microtiter plate and 100 µl of each of the peptide
concentrations were added into each test well, giving a final cell concentration of
5 × 105 CFU/ml. Each polystyrene plate was then aerobically incubated at 37 °C for
18–20 h without shaking, before measuring OD600 using a spectrophotometer plate
reader (Nanostar; BMG Labtech, Ayelsbury). A sigmoidal function was fitted to the





Where x is the peptide concentration, A and B are the OD600 of the positive and
negative controls respectively, D is a scaling factor and C is the IC50. The mean IC50
for each peptide was calculated from the results of four independent experiments,
with a single technical replicate each. Specific activity was calculated by plotting
IC50 (µM) multiplied by peptide length, against peptide length.
Minimum biocidal activity (MBC) for each peptide was assessed by removing 5
µl samples from all wells in the plate after overnight growth was completed
(immediately after OD600 assessment), then adding these samples to agar and
incubating them at 37 °C for 18–20 h. MBC was considered to be the lowest
concentration of each peptide in which no microorganism growth was observed
across three technical replicates. The mean MBC was calculated using data from
four independent experiments.
Determination of haemolytic activity (EC50). The haemolytic assay protocol was
based on those performed in previous studies25,46. Erythrocytes from defibrinated
horse blood were prepared by centrifugation at 2000 × g, 4 °C for 10 min. The pellet
was resuspended in PBS and the cells washed a further two times by centrifugation
(2000 × g, 4 °C for 10 min) and resuspension PBS a further two times. An ery-
throcyte test suspension was prepared by resuspending cells in PBS (20% v/v) and
was stored at 4 °C, prior to use. For assays, a 1% v/v cell suspension in PBS was
prepared and 100 µl aliquots transferred to polypropylene v-bottomed 96-well
microtiter plates. Dilutions of the stock solution of each peptide were plated into a
separate polypropylene 96-well microtiter plate (at double the final test con-
centrations), and 100 µl of each peptide solution was then transferred into 96-well
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02137-7 ARTICLE
COMMUNICATIONS BIOLOGY |           (2021) 4:605 | https://doi.org/10.1038/s42003-021-02137-7 | www.nature.com/commsbio 11
plate containing the test cell suspensions, before incubation at 37 °C for 1 h. The
final concentration of erythrocytes in the assays were ~5 × 107 cells/ml. Positive
and negative controls were included for each row of the plate, specifically 100 µl of
MilliQ water and 100 µl of PBS, respectively, each of which was added to 100 µl 1%
v/v cell suspension in PBS. After incubation, non-lysed cells were removed by
centrifugation at 2000 × g, 4 °C for 5 min. Finally, 100 µl of the supernatant was
transferred to a flat bottomed 96-well plate, and the haemoglobin content of the
supernatant was assessed by measured OD450 using a spectrophotometer plate
reader (Nanostar; BMG Labtech, Aylsbury, UK). Sigmodal curves based on Eq. 1,
with C in this case being EC50, were fitted to the resulting data, from which the
concentration of peptide resulting in 50% lysis of erythrocytes (EC50) was deter-
mined. Mean EC50 was calculated using data from four independent experiments,
each composed of a single technical replicate.
Stock solution turbidity (ODvis). Peptide stock solutions were prepared at 800 µM
in PBS with 5% v/v DMSO. About 100 µl of each peptide solution was then
transferred into 96-well plate and ODvis was then assessed by measuring OD600
using a spectrophotometer plate reader (Nanostar; BMG Labtech, Ayelsbury).
Mean ODvis was calculated using data from four repeat experiments, each com-
posed of a single technical replicate.
Dynamic light scattering (DLS). Peptide stock solutions were prepared at 800 µM
in PBS with 5% v/v DMSO. These were subjected to centrifugation at 2000 × g for
5 min at 20 °C (Eppendorf 5810 R; Eppendorf, Germany) to remove dust and
excessively large aggregates. 150 µl of the supernatant was transferred to a quartz
cuvette and the particle size distribution at 20 °C was determined using DLS
(Zetasizer NanoS; Malvern Instruments Ltd. Malvern, UK.). The number dis-
tribution (number of aggregates observed per aggregate diameter) from two
independent experiments with three technical replicates each was then used to
determine the mean aggregate size of each peptide across the 12 replicates.
Aggregates were then categorised into three classes, those producing small aggre-
gates (<10 nm diameter), moderate aggregates (diameter between 10 and 104 nm)
or large aggregates (>104 nm diameter).
Analytical ultracentrifugation. Peptide solutions were prepared at 800 µM in PBS
with 5% v/v DMSO, along with subsequent dilution in the same diluent at 80 µM.
Sedimentation equilibrium experiments were performed at 20 °C using an analy-
tical ultracentrifuge (ProteomLab XL-A; Beckman Coulter. Brea, USA). Double
carbon-epoxy cells were used to house the sample and reference buffer, and the
samples were subjected to centrifugation at 50,000 × g for 14 h. The absorbance
across the cell was measured at 280 nm at regular intervals during the run to
ascertain when equilibrium had occurred. Molecular masses at equilibrium were
determined as a single ideal species using the software Heteroanalysis47. Data
shown is from single independent experiments.
Lipid vesicle preparation. Phospholipid 1,2-dioleoyl-sn-glycero-phosphocholin
(DOPC) and 1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DOPG) were
obtained from Avanti Polar Lipids Inc (Alabama, USA). Neutral lipid bilayers were
formed from vesicles composed entirely of DOPC, whilst negatively charged
bilayers were composed of DOPC and DOPG at a ratio of 4:1 respectively. Lipids
were dissolved in chloroform in a glass vial and then dried to a film under nitrogen
gas. The lipids were then resuspended in HEPES buffer with 150 mM NaCl at 1
mg/ml and frozen at −80 °C for 30 min. This suspension was thawed, before
sonication at 10 Hz in 6 to 10 bursts, each lasting 1 min (MSE Soniprep 150 plus;
MSE Centrifuges Heathfield, UK). The size of the resulting vesicles was assessed
using DLS (with a 90° angle) to verify the vesicles were of a target diameter of 30
nm (Zetasizer NanoS; Malvern Instruments Ltd. Malvern, UK.) and the suspension
was stored in 200 µl aliquots 4 °C and used for experiments within 2 weeks of
preparation. Vesicle size was reassessed DLS before each use to ensure that they
were of a target diameter of 30 nm.
Membrane binding analysis. Membrane-peptide interactions were assessed using
a QCMD monitoring (Q-Sense Omega; Biolin Scientific. Manchester, UK); a subset
of heptapeptides (n= 29) was analysed, representing the 20 pairs of peptides that
had the largest differences in IC50 values whilst differing by only a single sub-
stitution in the peptide sequence. The stock vesicle suspension was diluted 1 in 5
with HEPES, and then 10 µl of 1 M CaCl2 was added. SiO2 sensors were cleaned
using UV/Ozone (Bioforce Nano Procleaner) and lipid bilayers were prepared by
depositing 0.2 mg/ml vesicle suspension at a rate of 25 µl/min for 5 min, followed
by removal of excess lipid by adding HEPES buffer onto the chip at 25 µl/min for 5
min. The frequency shift of the quartz chip was monitored throughout to ensure
that the lipid bilayer had formed correctly with a frequency of −25 Hz. Once a
stable bilayer had been formed, peptide solutions at 20 µM (chosen due to its
location centrally within the IC50 distributions of the peptides) in HEPES buffer
were deposited onto the bilayer at a rate of 20 µl/min for 9 min. Next, HEPES
buffer was added at a rate of 25 µl/min for 5 min, to remove any weakly bound or
unbound peptide. All parts of the experiment were performed at 20 °C. Frequency
and energy dissipation changes were recorded using Q-soft and the frequency shift
in the fifth octave was converted to mass shift using Q-Tools software (Q-sense
Omega, BiolinScientific/Q-Sense, Sweden). The mass change between the stable
bilayer and the end of the final washing step was then used to determine the
amount of peptide bound to the membrane. Four independent replicates were
performed and bound mass values shown are means over these replicates. Errors
shown are standard errors on the mean over all replicates. The R package chan-
gepoint (version 2.2.248) was used to determine the average mass of peptide bound
to the bilayer at each step.
Transmission electron microscopy. Peptides were prepared at 800 µM in PBS
with 5% v/v DMSO, and any excessively large aggregates or dust removed by
centrifugation (2000 × g, 5 min). Further dilutions (80 µM) were prepared in PBS
with 5% v/v DMSO, and the latter diluent was also used to prepare control (peptide-
free) grids. Carbon film 200 mesh copper transmission electron microscope (TEM)
grids (Agar Scientific Ltd. Stanstead, UK) were initially functionalized using a glow
discharger (K100X; Quorum technologies Ltd. Laughton, UK) under a current of 25
mA for 30 sec. These were then placed onto 10 µl droplets of each test sample
solution for 1 min, and then transferred onto 10 µl droplets of 1% w/v uranyl acetate
for a further minute. Excess solution was removed using filter paper and sample
grids were air dried for at least 1 h. Grids were imaged using a Tecnai™ T12 BioTwin
TEM (FEI Company. Hillsboro, USA). Images were cropped and scale bars were
added using ImageJ. Images are representative of single independent experiments.
Scanning electron microscopy (SEM). Single P. aeruginosa colonies were isolated
from agar cultures and added to 10 ml of broth, before incubation for 18–20 h at
37 °C. Cells were then harvested by centrifugation of 1 ml of the broth culture at
2000 × g for 5 min (MiniSpin®; Eppendorf. Hamburg, Germany), and the resulting
pellet suspended in PBS. This was repeated twice to wash cells, before diluting to
prepare a microbial suspension of ~107 CFU/ml in PBS (based on measurement of
OD600). This was treated with test peptides (RRRRRRR or RWWRWWR), by
adding 200 µl of peptide (at 160 or 800 µM) to 200 µl of the bacterial inoculum,
resulting in final peptide concentration of 80 and 400 µM. The mixtures were then
incubated at 37 °C for 1 h. Controls were also prepared in parallel, in which bac-
teria were treated with 200 µl PBS containing 5% v/v DMSO.
After incubation, 100 µl of each sample was deposited on to poly-L-lysine
treated mica sheets (Agar Scientific Ltd; Stansted, UK). Samples were fixed by
applying 2.5% w/v gluteraldehyde, 4% w/v paraformaldehyde in 100 mM HEPES to
each mica sheet and incubating overnight at 4 °C. Mica sheets were washed in
MilliQ water and dehydrated through 10 min exposures to ethanol at 50, 60, 70, 90
and 100% ethanol (latter wash was carried out twice). Critical point drying (CPD)
was then performed (K850; Quorum Technologies Ltd. Laughton, UK). The sample
was sputter coated with Au under argon gas using a sputter coater (SC7620 Mini
sputter coater; Quorum Technologies Ltd. Laughton, UK) for a period of 75 sec
under a current of 18 mA. Samples were imaged by SEM using a Quanta™ FEG
250 scanning electron microscope (FEI Company, Hillsboro, USA). Images were
cropped and scale bars were added using ImageJ. Images are representative of three
independent experiments.
Atomic force microscopy (AFM). A suspension of P. aeruginosa at ~107 CFU/ml
in PBS was prepared as for SEM; 500 µl of this suspension was incubated with 500
µl of RWWRWWR peptide (200 µM in PBS; 5% v/v DMSO) at 37 °C with shaking
at 200 rpm for 45 min. As a negative control, 500 µl bacterial suspension was
incubated with PBS containing 5% v/v DMSO. Samples of 50 µl were withdrawn
from the suspensions at 2, 15 and 45 min for imaging by AFM.
Chips were prepared by adsorbing 50 µl of poly-L-lysine onto a cleaved mica
chip for 3 min. Excess poly-L-lysine was washed off by adding 10 × 200 µl aliquots
of MilliQ water and excess water was removed using filter paper. Test samples were
deposited onto the chips and left to adhere for 1–2 min, before further washing
using 10 × 200 µl aliquots of MilliQ water, blotting off excess with filter paper,
before leaving chips to air-dry overnight.
Chips were scanned using a Bruker multimode 8 (Bruker, Billerica, USA) in
ScanAsyst air mode. All images were taken at a resolution of 512 points per
dimension unless stated otherwise, and are representative of single technical
experiments. Images obtained were processed and different length measurements
were performed using Gwyddion version 2.48 (http://gwyddion.net/).
Measurements were taken of the long axis length, short axis length and maximum
vertical height of the bacterium above the chip surface. Measurements were taken
over six different bacteria (n= 6).
Statistics and reproducibility. R software (version 3.5.0) was used for the majority
of analyses performed. Graphs were plotted using the ggplot2 and ggpubr packages
in R (versions 3.3.2 and 0.4.0 respectively). Two-dimensional LOESS smoothing
was carried out using the geom_smooth function in the ggplot2 package. Unless
otherwise stated, all errors reported are ±s.e.m. The function used to calculate
Spearman’s Rho was the spearman.test function from the pspearman R pack-
age (version 0.3-0), and the AS89 approximation algorithm used in this analysis.
Tukey tests and one-way ANOVA analyses were performed using the stats package
in R. All statistical testing performed was two-sided. The statistical model shown in
Fig. 1c was created by regressing the 90% quantile of the logged IC50 value against
peptide length for all combinations of length and organism where there were any
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active peptides (n= 240, 224 and 224 peptides for S. aureus, P. aeruginosa and C.
albicans, respectively). A logistic curve was used, estimating a common inactive
intercept among organisms and the remaining three parameters (corresponding to
active intercept, midpoint and slope) free to vary among organisms. The credibility
intervals for the maximum specific activity against each organism were estimated
using quantiles of 8000 draws from the model’s posterior distribution. Variance was
allowed to increase with length as this was found to improve the model (difference
in LOOIC= 3.7 ± 3.0). The model was fitted using the brms package (version
2.13.049) using the asym_laplace family and four MCMC chains, each with 2000
iterations of burn-in, checking convergence numerically (Rhat= 1.00 throughout)
and visually. Priors were taken from a similar logistic model, not accounting for any
variation among organisms, fitted using the gnls function in the nlme package
(version 3.1-13750). A bivariate model of ODvis and the logarithm of IC50 as logistic
functions of length (n= 254 peptides), was fit in the same way except using robust
regression (the ‘student’ family) and including a residual correlation between the
variables. For all boxplots shown, the centre line in the box indicates the median of
the data, the interquartile range is indicated by the box with the edges located at Q1
and Q3, and the whiskers of the plot indicate Q1-1.5xIQR and Q3+1.5xIQR.
For the antimicrobial and haemolytic assays four biological replicates were used
(n= 4). In the case of the antimicrobial assays biological replicates were taken as
different cultures from stock, and for the haemolytic activities, different batches from
supplier were taken as biological replicates. For inhibitory and haemolytic assays a
single technical replicate was performed for each biological replicate, however for
microbiocidal assays three technical replicates were performed. For DLS analysis two
independent experiments were performed (n= 2), AUC was performed using a
single independent experiment (n= 1), whilst for stock solution turbidity analysis
and membrane binding analysis four independent experiments were performed (n
= 4). Independent experiments in these cases were taken as these performed with
different syntheses of the peptides. For stock solution turbidity analysis, AUC and
membrane binding analysis single technical replicates were performed for each
independent experiment, whilst for DLS analysis three technical replicates were
performed for each independent experiment. For the SEM analysis three biological
replicates were implemented (n= 3) whilst for AFM one biological replicate was
used (n= 1). As with the antimicrobial assays, biological replicates were taken as
being different cultures generated from stock. A single technical replicate was
performed for each biological replicate in both SEM and AFM experiments.
Landscape analysis. For the antimicrobial and haemolytic activities (reciprocal
IC50 (1/IC50), MBC (1/MBC) and EC50 (1/EC50)) were used as the landscape
variables. Peak fraction was determined as the fraction of peptides within the
landscape where activity was greater than the nearest neighbours (Ai > Ann). Ann.
Neighbours were calculated using the raw longest common substring distances
(defined as the number of deletions in both sequences required for the sequences to
be equal). Deviation from additivity was defined as the sum of residuals squared for
a linear model fit through the landscapes divided by the average slope of the linear
model, which is often referred to as the roughness over slope or r/s. The peak
fraction and r/s parameter are based on work by Szendro et al.51. Network plots
were created by connecting sequences at an edit distance (restricted
Damerau–Levenshtein distance) of 1, and laid out in three dimensions using a
Fruchterman and Reingold algorithm using the sna and rgl packages in R. Dis-
tances were calculated using the stringdist R package (version 0.9.5.5).
Reporting Summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The raw data and R syntax to reproduce all the analyses, figures, tables and
supplementary tables in the published article are available as collection on
Figshare (https://doi.org/10.6084/m9.figshare.c.5104931)52. All other data are available
from the corresponding author on reasonable request.
Code availability
The R syntax to reproduce all the analyses, figures, tables and supplementary tables in the
published article are available as a collection in Figshare (https://doi.org/10.6084/m9.
figshare.c.5104931)52. All other code is available from the corresponding author on
reasonable request.
Received: 9 August 2020; Accepted: 29 March 2021;
References
1. Zhang, M., Zhao, J. & Zheng, J. Molecular understanding of a potential
functional link between antimicrobial and amyloid peptides. Soft Matter 10,
7425–7451 (2014).
2. Brogden, K. A., Ackermann, M., McCray, P. B. & Tack, B. F. Antimicrobial
peptides in animals and their role in host defences. Int. J. Antimicrob. Agents
22, 465–478 (2003).
3. Hassan, M., Kjos, M., Nes, I. F., Diep, D. B. & Lotfipour, F. Natural
antimicrobial peptides from bacteria: characteristics and potential applications
to fight against antibiotic resistance. J. Appl. Microbiol. 113, 723–736 (2012).
4. Blondelle, S. E. & Houghten, R. A. Novel antimicrobial compounds identified
using synthetic combinatorial library technology. Trends Biotechnol. 14, 60–65
(1996).
5. Strøm, M. B. et al. The pharmacophore of short cationic antibacterial peptides.
J. Med. Chem. 46, 1567–1570 (2003).
6. Svendsen, J. S. M., Grant, T. M., Rennison, D., Brimble, M. A. & Svenson, J.
Very short and stable lactoferricin-derived antimicrobial peptides: design
principles and potential uses. Acc. Chem. Res. 52, 749–759 (2019).
7. Mikut, R. et al. Improving short antimicrobial peptides despite elusive rules for
activity. Biochim. Biophys. Acta 1858, 1024–1033 (2016).
8. Kim, H., Jang, J. H., Kim, S. C. & Cho, J. H. De novo generation of short
antimicrobial peptides with enhanced stability and cell specificity. J.
Antimicrob. Chemother. 69, 121–132 (2014).
9. Lee, S.-H. et al. De novo generation of short antimicrobial peptides with
simple amino acid composition. Regul. Pept. 166, 36–41 (2011).
10. Albada, H. B. et al. Tuning the activity of a short Arg-Trp antimicrobial
peptide by lipidation of a C- or N-terminal lysine side-chain. ACS Med. Chem.
Lett. 3, 980–984 (2012).
11. Mishra, A., Choi, J., Moon, E. & Baek, K.-H. Tryptophan-rich and proline-rich
antimicrobial peptides. Molecules 23, 815 (2018).
12. Strøm, M. B., Rekdal, O. & Svendsen, J. S. Antimicrobial activity of short
arginine- and tryptophan-rich peptides. J. Pept. Sci. 8, 431–437 (2002).
13. Chan, D. I., Prenner, E. J. & Vogel, H. J. Tryptophan- and arginine-rich
antimicrobial peptides: structures and mechanisms of action. Biochim.
Biophys. Acta 1758, 1184–1202 (2006).
14. Jin, L. et al. A designed tryptophan- and lysine/arginine-rich antimicrobial
peptide with therapeutic potential for clinical antibiotic-resistant Candida
albicans Vaginitis. J. Med. Chem. 59, 1791–1799 (2016).
15. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 415,
389–395 (2002).
16. Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors
in bacteria? Nat. Rev. Microbiol. 3, 238–250 (2005).
17. Fink, A. L. Protein aggregation: folding aggregates, inclusion bodies and
amyloid. Fold. Des. 3, R9–R23 (1998).
18. Wozniak, M. A., Itzhaki, R. F., Shipley, S. J. & Dobson, C. B. Herpes simplex
virus infection causes cellular β-amyloid accumulation and secretase
upregulation. Neurosci. Lett. 429, 95–100 (2007).
19. Soscia, S. J. et al. The Alzheimer’s disease-associated amyloid β-protein is an
antimicrobial peptide. PLoS ONE 5, e9505 (2010).
20. Golde, T. E. Host immune defence, amyloid-β peptide and Alzheimer disease:
Alzheimer disease. Nat. Rev. Neurol. 12, 433–434 (2016).
21. Saravanan, R. et al. Design of short membrane selective antimicrobial peptides
containing tryptophan and arginine residues for improved activity, salt-
resistance, and biocompatibility. Biotechnol. Bioeng. 111, 37–49 (2014).
22. Abramson, H. A. & Moyer, L. S. The electrical charge of mammalian red
blood cells. J. Gen. Physiol. 19, 601–607 (1936).
23. Meade, K. G. et al. Directed alteration of a novel bovine β-defensin to improve
antimicrobial efficacy against methicillin-resistant Staphylococcus aureus
(MRSA). Int. J. Antimicrob. Agents 32, 392–397 (2008).
24. Browne, K. et al. A new era of antibiotics: the clinical potential of
antimicrobial peptides. Int. J. Mol. Sci. 21, 7047 (2020).
25. Liu, Z. et al. Length effects in antimicrobial peptides of the (RW)n series.
Antimicrob. Agents Chemother. 51, 597–603 (2007).
26. Kabsch, W. & Sander, C. Dictionary of protein secondary structure: pattern
recognition of hydrogen-bonded and geometrical features. Biopolymers 22,
2577–2637 (1983).
27. Maccari, G. et al. Antimicrobial peptides design by evolutionary multiobjective
optimization. PLoS Comput. Biol. 9, e1003212 (2013).
28. Kelly, B. A. et al. Apolipoprotein E-derived antimicrobial peptide analogues
with altered membrane affinity and increased potency and breadth of
activity: aromatic substitution of ApoE-derived AMPs. FEBS J. 274,
4511–4525 (2007).
29. Knight, C. G. et al. Array-based evolution of DNA aptamers allows
modelling of an explicit sequence-fitness landscape. Nucleic Acids Res. 37,
e6–e6 (2009).
30. Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind
specific ligands. Nature 346, 818–822 (1990).
31. Nozaki, Y. & Tanford, C. The solubility of amino acids and two glycine
peptides in aqueous ethanol and dioxane solutions establishment of a
hydrophobicity scale. J. Biol. Chem. 246, 2211–2217 (1971).
32. Argos, P., Rao, J. K. & Hargrave, P. A. Structural prediction of membrane-
bound proteins. Eur. J. Biochem. 128, 565–575 (1982).
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02137-7 ARTICLE
COMMUNICATIONS BIOLOGY |           (2021) 4:605 | https://doi.org/10.1038/s42003-021-02137-7 | www.nature.com/commsbio 13
33. Fauchere, J.-L. & Pliska, V. Hydrophobic parameters pi of amino-acid side
chains from the partitioning of N-acetyl-amino-acid amides. Eur. J. Med.
Chem. 18, 369–375 (1983).
34. Yin, L. M., Edwards, M. A., Li, J., Yip, C. M. & Deber, C. M. Roles of
hydrophobicity and charge distribution of cationic antimicrobial peptides in
peptide-membrane interactions. J. Biol. Chem. 287, 7738–7745 (2012).
35. Trevino, S. R., Scholtz, J. M. & Pace, C. N. Measuring and increasing protein
solubility. J. Pharm. Sci. 97, 4155–4166 (2008).
36. Mahler, H.-C., Friess, W., Grauschopf, U. & Kiese, S. Protein aggregation:
pathways, induction factors and analysis. J. Pharm. Sci. 98, 2909–2934
(2009).
37. Pekar, A. & Sukumar, M. Quantitation of aggregates in therapeutic proteins
using sedimentation velocity analytical ultracentrifugation: practical
considerations that affect precision and accuracy. Anal. Biochem. 367,
225–237 (2007).
38. Brothers, H. M., Gosztyla, M. L. & Robinson, S. R. The physiological roles of
amyloid-β peptide hint at new ways to treat Alzheimer’s disease. Front. Aging
Neurosci. 10, 118 (2018).
39. Nichols, M. R. et al. Biophysical comparison of soluble amyloid-β(1-42)
protofibrils, oligomers, and protofilaments. Biochemistry 54, 2193–2204
(2015).
40. Mitik-Dineva, N. et al. Escherichia coli, Pseudomonas aeruginosa, and
Staphylococcus aureus attachment patterns on glass surfaces with nanoscale
roughness. Curr. Microbiol. 58, 268–273 (2009).
41. Hartmann, M. et al. Damage of the bacterial cell envelope by antimicrobial
peptides gramicidin S and PGLa as revealed by transmission and
scanning electron microscopy. Antimicrob. Agents Chemother. 54, 3132–3142
(2010).
42. Ding, L., Chi, E. Y., Schanze, K. S., Lopez, G. P. & Whitten, D. G. Insight into
the mechanism of antimicrobial conjugated polyelectrolytes: lipid headgroup
charge and membrane fluidity effects. Langmuir 26, 5544–5550 (2010).
43. Kursa, M. B. & Rudnicki, W. R. Feature selection with the Boruta package. J.
Stat. Softw. 36, 1–13 (2010).
44. Eisenberg, D., Weiss, R. M. & Terwilliger, T. C. The hydrophobic moment
detects periodicity in protein hydrophobicity. Proc. Natl Acad. Sci. USA 81,
140–144 (1984).
45. Keil, B. Specificity of Proteolysis (Springer, 1992).
46. Nguyen, L. T. et al. Serum stabilities of short tryptophan- and arginine-rich
antimicrobial peptide analogs. PLoS ONE 5, e12684 (2010).
47. Cole, J. L. Analysis of heterogeneous interactions. Methods Enzymol. 384,
212–232 (2004).
48. Killick, R. & Eckley, Ekley, I. A. changepoint: An R Package for Changepoint
Analysis. J. Stat. Softw. 58, 1–19 (2014).
49. Bürkner, P. C. brms: an R package for Bayesian multilevel models using Stan.
J. Stat. Softw. 80, 1–28 (2017).
50. Pinheiro, J. C. & Bates, D. M.Mixed-Effects Models in S and S-PLUS (Springer,
2000).
51. Szendro, I. G., Schenk, M. F., Franke, J., Krug, J. & Visser, J. A. G. M. de
Quantitative analyses of empirical fitness landscapes. J. Stat. Mech. Theory
Exp. 2013, P01005 (2013).
52. Clark, S., Jowitt, T., Harris, L. K., Knight, C. & Dobson, C. The lexicon of
antimicrobial peptides: a complete set of arginine and tryptophan sequences.
figshare https://doi.org/10.6084/m9.figshare.c.5104931 (2021).
Acknowledgements
The authors acknowledge the BBSRC Doctoral training partnership (BB/M011208/1), the
family of Sir Kenneth Murray and the University of Manchester for support for SC. We
would also like to thank Professor Douglas Kell (University of Liverpool) for connecting
the authors and initiating our collaboration, the staff of the BioAFM, biomolecular
analysis and electron microscopy facilities of the University of Manchester’s Faculty of
Biology, Medicine and Health for technical support and Pippa Knight for editing the
Supplementary Movie 1.
Author contributions
S.C. carried out experimental work, assisted by T.A.J. in design and execution of the AUC
and membrane binding studies. S.C., L.K.H., C.G.K. and C.B.D. conceived the study, and
contributed to the design of experiments, interpretation of the results, wrote and edited
the manuscript.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information The online version contains supplementary material
available at https://doi.org/10.1038/s42003-021-02137-7.
Correspondence and requests for materials should be addressed to C.B.D.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2021
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-021-02137-7
14 COMMUNICATIONS BIOLOGY |           (2021) 4:605 | https://doi.org/10.1038/s42003-021-02137-7 | www.nature.com/commsbio
